Lipid structures and hormonal control Flashcards
Risk factors for CAD (epidemiology)
age - major male cigarettes DM cholesterol BP family history of premature CAD inflammatory biomarkers overweight, obesity
Pathophysiology evidence for CAD
Vulnerable human atherosclerotic plaque
LDL-C, hypertension, diabetes and smoking lead to endothelial cell dysfunction
- v/c
- increased pltaelet and leukocyte adhesion
- smooth muscel cell migration and growth
-increased lipid deposition with reduced clearance
Genetic risk factors for CAD
any that increase LDL-C/TAG
Clinical trial evidence for CAD
greater reduction in LDL-C = lowered risk
more effective to treat LDL-C than HTN
secondary prevention more effective
Lipid lengths
short: 2-5 Medium: 6-12 Long: 12-18 Very long: >18 each have a unique acyl-CoA dehydrogenase (but overlaps)
Essential lipids
linoleic
alpha-linoleic
arachidonic acids
Trans fats
arise form partially hydrogenated plant oils, rancid plant oils and ruminant animal fats
effects on lipid: increase LDL, lower HDL
Ether glycerolipid structure
Glycerol
C1 - FA (ETHER linkage)
C2 - FA (as above)
C3 - phosphate head group
Glycerophospholipid structure
Glycerol + 2 FA side chains (ester linkage) + P-head group
Phosphatidylcholine (lecithin)
R1 = long chain, saturated
R2 = long chain, unsaturated
Marker of fetal lung maturity
Lecithin: sphingomyelin ratio
L:S >2 mature - neonatal RDS less likely
immature <1.5
Phosphatidylethanolamine (cephalin)
usually R1 = stearic acid
R2 = long-chain unsatuated
structural membrane phospholipids, esp in CNS
Phosphatidylserine
membrane structural phospholipid
synthesized by headgroup exchange PE + Serine –> PS + ethanolamine
Phosphatidylinositol
R1: stearic acid
R2: arachidonic acid
low concentrations in membranes
mediator of intracellular signals
Phosphatidylglycerol
major component of mitochondrial membranes
component of pulmonary surfactant - can also be used as a marker for fetal lung maturity